Literature DB >> 27813100

Is aspirin desensitization indicated for the treatment recalcitrant chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease?

Joshua M Levy1,2, Timothy L Smith1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27813100      PMCID: PMC5360470          DOI: 10.1002/lary.26377

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


× No keyword cloud information.
  5 in total

Review 1.  International Consensus Statement on Allergy and Rhinology: Rhinosinusitis.

Authors:  Richard R Orlandi; Todd T Kingdom; Peter H Hwang; Timothy L Smith; Jeremiah A Alt; Fuad M Baroody; Pete S Batra; Manuel Bernal-Sprekelsen; Neil Bhattacharyya; Rakesh K Chandra; Alexander Chiu; Martin J Citardi; Noam A Cohen; John DelGaudio; Martin Desrosiers; Hun-Jong Dhong; Richard Douglas; Berrylin Ferguson; Wytske J Fokkens; Christos Georgalas; Andrew Goldberg; Jan Gosepath; Daniel L Hamilos; Joseph K Han; Richard Harvey; Peter Hellings; Claire Hopkins; Roger Jankowski; Amin R Javer; Robert Kern; Stilianos Kountakis; Marek L Kowalski; Andrew Lane; Donald C Lanza; Richard Lebowitz; Heung-Man Lee; Sandra Y Lin; Valerie Lund; Amber Luong; Wolf Mann; Bradley F Marple; Kevin C McMains; Ralph Metson; Robert Naclerio; Jayakar V Nayak; Nobuyoshi Otori; James N Palmer; Sanjay R Parikh; Desiderio Passali; Anju Peters; Jay Piccirillo; David M Poetker; Alkis J Psaltis; Hassan H Ramadan; Vijay R Ramakrishnan; Herbert Riechelmann; Hwan-Jung Roh; Luke Rudmik; Raymond Sacks; Rodney J Schlosser; Brent A Senior; Raj Sindwani; James A Stankiewicz; Michael Stewart; Bruce K Tan; Elina Toskala; Richard Voegels; De Yun Wang; Erik K Weitzel; Sarah Wise; Bradford A Woodworth; Peter-John Wormald; Erin D Wright; Bing Zhou; David W Kennedy
Journal:  Int Forum Allergy Rhinol       Date:  2016-02       Impact factor: 3.858

2.  Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.

Authors:  Monika Świerczyńska-Krępa; Marek Sanak; Grażyna Bochenek; Paweł Stręk; Adam Ćmiel; Anna Gielicz; Hanna Plutecka; Andrzej Szczeklik; Ewa Niżankowska-Mogilnicka
Journal:  J Allergy Clin Immunol       Date:  2014-04-24       Impact factor: 10.793

3.  An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease.

Authors:  Marcus Shaker; Ano Lobb; Pamela Jenkins; Daniel O'Rourke; Steve K Takemoto; Salil Sheth; Thomas Burroughs; Mark S Dykewicz
Journal:  J Allergy Clin Immunol       Date:  2007-08-22       Impact factor: 10.793

Review 4.  Aspirin desensitization for aspirin-exacerbated respiratory disease (Samter's Triad): a systematic review of the literature.

Authors:  Jason J Xu; Leigh Sowerby; Brian W Rotenberg
Journal:  Int Forum Allergy Rhinol       Date:  2013-07-16       Impact factor: 3.858

5.  Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease.

Authors:  K Fruth; B Pogorzelski; I Schmidtmann; J Springer; N Fennan; N Fraessdorf; A Boessert; D Schaefer; J Gosepath; W J Mann
Journal:  Allergy       Date:  2013-03-07       Impact factor: 13.146

  5 in total
  3 in total

1.  Endocannabinoid receptor CB2R is significantly expressed in aspirin-exacerbated respiratory disease: a pilot study.

Authors:  Alessia Corrado; Monica Battle; Sarah K Wise; F Eun-Hyung Lee; David M Guidot; John M DelGaudio; Samuel A Molina; Joshua M Levy
Journal:  Int Forum Allergy Rhinol       Date:  2018-06-13       Impact factor: 3.858

Review 2.  Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis.

Authors:  Zheng Liu; Jianjun Chen; Lei Cheng; Huabin Li; Shixi Liu; Hongfei Lou; Jianbo Shi; Ying Sun; Dehui Wang; Chengshuo Wang; Xiangdong Wang; Yongxiang Wei; Weiping Wen; Pingchang Yang; Qintai Yang; Gehua Zhang; Yuan Zhang; Changqing Zhao; Dongdong Zhu; Li Zhu; Fenghong Chen; Yi Dong; Qingling Fu; Jingyun Li; Yanqing Li; Chengyao Liu; Feng Liu; Meiping Lu; Yifan Meng; Jichao Sha; Wenyu She; Lili Shi; Kuiji Wang; Jinmei Xue; Luoying Yang; Min Yin; Lichuan Zhang; Ming Zheng; Bing Zhou; Luo Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2020-03       Impact factor: 5.764

3.  Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.

Authors:  Joaquim Mullol; Tanya M Laidlaw; Claus Bachert; Leda P Mannent; G Walter Canonica; Joseph K Han; Jorge F Maspero; Cesar Picado; Nadia Daizadeh; Benjamin Ortiz; Yongtao Li; Marcella Ruddy; Elizabeth Laws; Nikhil Amin
Journal:  Allergy       Date:  2021-10-01       Impact factor: 14.710

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.